Global
CN
EN
HOME
ABOUT US
About Laekna
Core Management Team
Board of Directors
Milestones
Scientific Advisory Board
Core Investors
Honors & Awards
R&D
R&D
Therapeutic Areas
Candidates
Pipeline
Clinical Trials
PARTNERSHIPS
Strategic Partners
Business Development
Holistic Approach
BD Contact
INVESTORS
Corporate Governance
Financial Results
Announcements and Circulars
IR Calendar
Listing Documents
NEWS
Press Releases
Media Coverage
CAREERS
Global Team
Career Development
Jobs
My Laekna
CONTACT US
Contact Us
Leave Message
RSS Feeds
INVESTOR RELATIONS
CURE FOR A BETTER FUTURE
Scroll down to see more
Announcements and Circulars
2024
2023
November 21, 2024
[Placing / Issue of Shares under a General Mandate]
More
November 20, 2024
[VOLUNTARY ANNOUNCEMENT]
- CLINICAL COLLABORATION WITH LILLY ON LAE102 IN THE U.S. FOR THE TREATMENT OF OBESITY
More
November 05, 2024
[Monthly Returns]
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
More
October 18, 2024
[Results of EGM/SGM]
- POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 18 OCTOBER 2024
More
October 18, 2024
[VOLUNTARY ANNOUNCEMENT]
- SUBCUTANEOUS COHORT INITIATED IN PHASE I CLINICAL TRIAL OF LAE102 FOR THE TREATMENT OF OBESITY
More
October 07, 2024
[Monthly Returns]
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
More
<
1
2
3
4
7
>
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
Name
*
Email
*
Company
Occupation
News
Positions
Follow us on Linkedin
HOME
ABOUT US
R&D
PARTNERSHIPS
INVESTORS
NEWS
CAREERS
CONTACT US
PRIVACY POLICY
占位
Global
—English
|
中国
—简体中文